For help on how to get the results you want, see our search tips.
1557 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Sycrest (updated)
asenapine (as maleate) , Bipolar Disorder
Date of authorisation: 01/09/2010, Revision: 18, Authorised, Last updated: 19/02/2021 -
List item
Human medicine European public assessment report (EPAR): Duavive (updated)
oestrogens conjugated, bazedoxifene, Postmenopause
Date of authorisation: 16/12/2014, Revision: 12, Authorised, Last updated: 19/02/2021 -
List item
Human medicine European public assessment report (EPAR): Recarbrio (updated)
imipenem monohydrate, cilastatin sodium, relebactam monohydrate, Gram-Negative Bacterial Infections
Date of authorisation: 13/02/2020,
, Revision: 2, Authorised, Last updated: 19/02/2021
-
List item
Human medicine European public assessment report (EPAR): Nuceiva (updated)
Botulinum toxin type A, Skin Aging
Date of authorisation: 27/09/2019,, Revision: 2, Authorised, Last updated: 19/02/2021
-
List item
Human medicine European public assessment report (EPAR): Stocrin (updated)
efavirenz, HIV Infections
Date of authorisation: 28/05/1999, Revision: 45, Authorised, Last updated: 18/02/2021 -
List item
Human medicine European public assessment report (EPAR): Vimpat (updated)
lacosamide, Epilepsy
Date of authorisation: 29/08/2008, Revision: 34, Authorised, Last updated: 18/02/2021 -
List item
Human medicine European public assessment report (EPAR): Palonosetron Accord (updated)
Palonosetron, Vomiting, Nausea, Cancer
Date of authorisation: 26/05/2016,
, Revision: 4, Authorised, Last updated: 18/02/2021
-
List item
Human medicine European public assessment report (EPAR): Adrovance (updated)
colecalciferol, alendronic acid (as sodium trihydrate), Osteoporosis, Postmenopausal
Date of authorisation: 04/01/2007, Revision: 22, Authorised, Last updated: 18/02/2021 -
List item
Human medicine European public assessment report (EPAR): Zavicefta (updated)
avibactam sodium, ceftazidime pentahydrate, Pneumonia, Bacterial, Soft Tissue Infections, Pneumonia, Urinary Tract Infections, Gram-Negative Bacterial Infections
Date of authorisation: 23/06/2016,, Revision: 11, Authorised, Last updated: 18/02/2021
-
List item
Human medicine European public assessment report (EPAR): Crysvita (updated)
Burosumab, Hypophosphatemia, Familial, Hypophosphatemic Rickets, X-Linked Dominant
Date of authorisation: 19/02/2018,, 
, 
, Revision: 7, Authorised, Last updated: 18/02/2021
-
List item
Human medicine European public assessment report (EPAR): Clopidogrel Taw Pharma (previously Clopidogrel Apotex) (updated)
clopidogrel (as besilate), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 16/10/2009,, Revision: 20, Authorised, Last updated: 17/02/2021
-
List item
Human medicine European public assessment report (EPAR): Lenalidomide Accord (updated)
lenalidomide, Multiple Myeloma
Date of authorisation: 20/09/2018,, Revision: 5, Authorised, Last updated: 17/02/2021
-
List item
Human medicine European public assessment report (EPAR): Enzepi (updated)
pancreas powder, Exocrine Pancreatic Insufficiency
Date of authorisation: 29/06/2016,, Revision: 1, Withdrawn, Last updated: 17/02/2021
-
List item
Human medicine European public assessment report (EPAR): EndolucinBeta (updated)
lutetium (177Lu) chloride, Radionuclide Imaging
Date of authorisation: 06/07/2016, Revision: 8, Authorised, Last updated: 16/02/2021 -
List item
Human medicine European public assessment report (EPAR): Piqray (updated)
Alpelisib, Breast Neoplasms
Date of authorisation: 27/07/2020,, Revision: 2, Authorised, Last updated: 16/02/2021
-
List item
Human medicine European public assessment report (EPAR): Darunavir Mylan (updated)
darunavir, HIV Infections
Date of authorisation: 03/01/2017,, Revision: 8, Authorised, Last updated: 16/02/2021
-
List item
Human medicine European public assessment report (EPAR): Javlor (updated)
vinflunine, Carcinoma, Transitional Cell, Urologic Neoplasms
Date of authorisation: 21/09/2009, Revision: 9, Authorised, Last updated: 16/02/2021 -
List item
Human medicine European public assessment report (EPAR): Dafiro (updated)
amlodipine, valsartan, Hypertension
Date of authorisation: 15/01/2007, Revision: 27, Authorised, Last updated: 16/02/2021 -
List item
Human medicine European public assessment report (EPAR): Sprycel (updated)
dasatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Date of authorisation: 20/11/2006, Revision: 35, Authorised, Last updated: 16/02/2021 -
List item
Human medicine European public assessment report (EPAR): Vidaza (updated)
azacitidine, Myelodysplastic Syndromes
Date of authorisation: 17/12/2008,
, Revision: 20, Authorised, Last updated: 16/02/2021
-
List item
Human medicine European public assessment report (EPAR): Udenyca (updated)
pegfilgrastim, Neutropenia
Date of authorisation: 21/09/2018,, 
, Revision: 3, Withdrawn, Last updated: 15/02/2021
-
List item
Human medicine European public assessment report (EPAR): Ultomiris (updated)
ravulizumab, Hemoglobinuria, Paroxysmal
Date of authorisation: 02/07/2019,, Revision: 4, Authorised, Last updated: 15/02/2021
-
List item
Human medicine European public assessment report (EPAR): Mysildecard (updated)
sildenafil citrate, Hypertension, Pulmonary
Date of authorisation: 15/09/2016,, Revision: 3, Authorised, Last updated: 15/02/2021
-
List item
Human medicine European public assessment report (EPAR): Halaven (updated)
Eribulin, Breast Neoplasms, Liposarcoma
Date of authorisation: 17/03/2011, Revision: 22, Authorised, Last updated: 15/02/2021 -
List item
Human medicine European public assessment report (EPAR): Plavix (updated)
clopidogrel hydrogen sulfate, Stroke, Peripheral Vascular Diseases, Atrial Fibrillation, Myocardial Infarction, Acute Coronary Syndrome
Date of authorisation: 15/07/1998, Revision: 43, Authorised, Last updated: 12/02/2021